Treatments:Cancer
From Proteopedia
(Difference between revisions)
| (52 intermediate revisions not shown.) | |||
| Line 3: | Line 3: | ||
<td style="width:25%; vertical-align:top;border-width:1px;"> | <td style="width:25%; vertical-align:top;border-width:1px;"> | ||
=====Anti-CD20 [[Monoclonal Antibody]]===== | =====Anti-CD20 [[Monoclonal Antibody]]===== | ||
| - | * [[Arzerra]] - Generic: Ofatumumab | + | * [[Arzerra]] - Generic: [[Ofatumumab]] |
| - | * [[Rituxan]] - Generic: Rituximab | + | * [[Rituxan]] - Generic: [[Rituximab]] |
| + | * Bexxar - Generic: [[Tositumomab]] | ||
| + | =====Anti-melanoma [[Monoclonal Antibody]]===== | ||
| + | * Pembrolizumab - Generic: [[Keytruda]] | ||
| + | * [[Lenalidomide]] - Generic: Revlimid | ||
| + | See [[Treatment of multiple myeloma]] | ||
| + | =====Anti-prostate cancer===== | ||
| + | * [[Bicalutamide]] - Generic: Casodex | ||
| + | * [[Abiraterone acetate]] - Generic: Zytiga | ||
| + | * Enzalutamide. | ||
| + | * [[Treatment for malignant neoplasms of prostate]] | ||
| + | =====Anti-myeloma===== | ||
| + | * [[Bortezomib]] - Generic: Velcade | ||
| + | =====Anti-acute lymphocytic leukemia===== | ||
| + | * [[Imatinib]] - Generic: Gleevec; See [[Treatment of acute lymphocytic leukemia]] | ||
| + | =====Anti-non-small cell lung cacinoma===== | ||
| + | * [[Afatinib]] - Generic: Gilotrif; See [[Treatment non-small cell lung carcinoma]] | ||
| + | * [[Erlotinib]] - Generic: Tarceva; See [[Treatment of pancreatic cancer]] | ||
| + | * [[Gefitinib]] - Generic: Iressa | ||
| + | * [[Lapatinib]] - Generic: Tykerb | ||
| + | =====B-Raf Kinase Inhibitor===== | ||
| + | * Zelboraf - Generic: Vemurafenib (Formerly: PLX-4032) | ||
=====Chemotherapy===== | =====Chemotherapy===== | ||
| - | * [[Platinol]] - Generic: Cisplatin | + | * [[Platinol]] - Generic: [[Cisplatin]] |
| - | =====[[Epidermal Growth Factor Receptor]] | + | =====[[Dihydrofolate reductase|Dihydrofolate Reductase]] Inhibitor===== |
| - | * [[Herceptin]] - Generic: Trastuzumab | + | * Alimta - Generic: Pemetrexed |
| - | * [[Iressa]] - Generic: Gefitinib | + | * Folotyn - Generic: Pralatrexate |
| - | * [[Tarceva]] - Generic: Erlotinib | + | * [[Methotrexate]] - Trade names: [[Trexall]], [[Rheumatrex]], [[Otrexup]] |
| - | * [[Tykerb]] - Generic: Lapatinib | + | * Raltitrexed |
| + | =====[[Epidermal Growth Factor Receptor]] Inhibitors===== | ||
| + | * [[Herceptin]] - Generic: [[Trastuzumab]] | ||
| + | * [[Iressa]] - Generic: [[Gefitinib]] | ||
| + | * [[Tarceva]] - Generic: [[Erlotinib]] | ||
| + | * [[Tykerb]] - Generic: [[Lapatinib]] | ||
=====Estrogen Receptor Modulator===== | =====Estrogen Receptor Modulator===== | ||
| - | * Evista - Generic: Raloxifene | + | * [[Evista]] - Generic: [[Raloxifene]] |
* Fareston - Generic: Toremifene | * Fareston - Generic: Toremifene | ||
| - | * Nolvadex - Generic: Tamoxifen | + | * [[Nolvadex]] - Generic: [[Tamoxifen]] |
| - | =====Multiple Receptor Tyrosine | + | =====mTOR inhibitor===== |
| - | * [[Gleevec]] - Generic: Imatinib | + | * Rapamune - Generic: Sirolimus ([[Rapamycin]]) |
| - | * [[Nexavar]] - Generic: Sorafenib | + | * Afinitor - Generic: Everolimus |
| - | * [[Sprycel]] - Generic: Dasatinib | + | * Torisel - Generic: Temsirolimus |
| - | * [[Sutent]] - Generic: Sunitinib | + | =====Multiple Receptor [[Tyrosine kinase]] ([[VEGFR]], PDGFR, [[EGFR]], KIT, Abl, RAF kinase) Inhibitors===== |
| - | * [[Tasigna]] - Generic: Nilotinib | + | * [[Gleevec]] - Generic: [[Imatinib]] |
| + | * [[Nexavar]] - Generic: [[Sorafenib]] | ||
| + | * [[Sprycel]] - Generic: [[Dasatinib]] | ||
| + | * [[Sutent]] - Generic: [[Sunitinib]] | ||
| + | * [[Tasigna]] - Generic: [[Nilotinib]] | ||
| + | * [[Ibrutinib]] - brand name: [[Imbruvica]] | ||
| + | See [[Treatment of chronic myelogenous leukemia]], [[Treatment of hepatocellular carcinoma]], [[Treatment of renal cell carcinoma]], [[Treatment of gastrointestinal stromal tumor]], [[VEGFR inhibitors]] and [[Tyrosine-kinase inhibitors]]. | ||
=====[[Vascular Endothelial Growth Factor]] Inhibitor===== | =====[[Vascular Endothelial Growth Factor]] Inhibitor===== | ||
| - | * [[Avastin]] - Generic: Bevacizumab | + | * [[Avastin]] - Generic: [[Bevacizumab]] |
| + | =====Poly ADP ribose polymerase (PARP) inhibitors===== | ||
| + | * [[Olaparib]] - brand name [[Lynparza]] | ||
| + | =====[[Cyclin-dependent kinases]] inhibitors===== | ||
| + | * [[Palbociclib]] - brand name [[Ibrance]] | ||
| + | * [[Abemaciclib]] - brand name [[Verzenio]] | ||
| + | * [[Ribociclib]] - brand name [[Kisqali]] | ||
| + | |||
| + | See also [[Anti-cancer drugs]], [[Anticancer drugs]] and [[RAF kinase inhibitors]] | ||
</td> | </td> | ||
</tr> | </tr> | ||
</table> | </table> | ||
__NOTOC__ | __NOTOC__ | ||
Current revision
Anti-CD20 Monoclonal Antibody
Anti-melanoma Monoclonal Antibody
See Treatment of multiple myeloma Anti-prostate cancer
Anti-myeloma
Anti-acute lymphocytic leukemia
Anti-non-small cell lung cacinoma
B-Raf Kinase Inhibitor
ChemotherapyDihydrofolate Reductase Inhibitor
Epidermal Growth Factor Receptor Inhibitors
Estrogen Receptor Modulator
mTOR inhibitor
Multiple Receptor Tyrosine kinase (VEGFR, PDGFR, EGFR, KIT, Abl, RAF kinase) Inhibitors
See Treatment of chronic myelogenous leukemia, Treatment of hepatocellular carcinoma, Treatment of renal cell carcinoma, Treatment of gastrointestinal stromal tumor, VEGFR inhibitors and Tyrosine-kinase inhibitors. Vascular Endothelial Growth Factor Inhibitor
Poly ADP ribose polymerase (PARP) inhibitorsCyclin-dependent kinases inhibitors
See also Anti-cancer drugs, Anticancer drugs and RAF kinase inhibitors |
Proteopedia Page Contributors and Editors (what is this?)
David Canner, Michal Harel, Alexander Berchansky, Karsten Theis
